PMID- 35722364 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2305-5839 (Print) IS - 2305-5847 (Electronic) IS - 2305-5839 (Linking) VI - 10 IP - 10 DP - 2022 May TI - Mitochondria-specific peptide amphiphiles induce mitochondrial dysfunction and peripheral T-cell lymphomas (PTCL) damage. PG - 570 LID - 10.21037/atm-22-2233 [doi] LID - 570 AB - BACKGROUND: Peripheral T-cell lymphomas (PTCL) are aggressive lymphomas with poor prognosis, and therefore, there is a pressing need to explore new targets or compounds. Mitochondria may serve as a potential therapeutic target for PTCL. A designed positively-charged segment (pKV) is anchored to the specific 15 amino acid sequence (MIASHLLAYFFTELN) to yield a cell-penetrating peptide (pHK-pKV) and a lipid chain (Pal) is conjugated to the N-terminus of pHK-pKV (Pal-pHK-pKV) are bioactive amphiphilic peptide assemblies targeting the interaction between mitochondrial voltage dependent anion channel 1 (VDAC1) and hexokinase II (HKII). METHODS: PTCL cell line H9 was treated with Pal-pHK-pKV and pHK-pKV, respectively. Cell proliferation in each group was measured by detecting cell viability and the corresponding marker Ki-67. Apoptosis was detected by immunofluorescence, flow cytometry and western blot. We also measured mitochondrial membrane potential, adenosine triphosphate (ATP) production, the cytochrome c distribution and the expression levels of B cell lymphoma 2 (BCL-2) and BCL-2 associated X protein (BAX). Western blot was used to detect the activation of the extracellular regulated protein kinases (ERK) signaling pathway. RESULTS: Pal-pHK-pKV and pHK-pKV with 20 microM blocked the interaction between VDAC1 and HKII, and detached HKII from mitochondria, which depolarized the mitochondrial membrane potential, induced mitochondria dysfunction, and decreased ATP production. The decreased ATP subsequently inhibited the activation of the ERK/BCL-2 pathway and increased the BAX/BCL-2 ratio. Cytochrome c was then released from the mitochondria and induced capase-3 activation and subsequently apoptosis. Additionally, decreased ATP induced the expression of FAS and then apoptosis. CONCLUSIONS: Mitochondria specific peptide amphiphiles induce mitochondrial dysfunction and provide a new approach for the treatment of PTCL. CI - 2022 Annals of Translational Medicine. All rights reserved. FAU - Sun, Qi AU - Sun Q AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Gui, Ailing AU - Gui A AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Zou, Aihua AU - Zou A AD - College of Chemistry and Materials Science, Shanghai Normal University, Shanghai, China. FAU - Yan, Yichen AU - Yan Y AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Qiu, Shi AU - Qiu S AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Zhu, Shun AU - Zhu S AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Liu, Wen AU - Liu W AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Zuo, Ji AU - Zuo J AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. FAU - Zhang, Qunling AU - Zhang Q AD - Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China. AD - Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Yang, Ling AU - Yang L AD - Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China. LA - eng PT - Journal Article PL - China TA - Ann Transl Med JT - Annals of translational medicine JID - 101617978 PMC - PMC9201132 OTO - NOTNLM OT - Amphiphilic peptides OT - apoptosis OT - mitochondrial dysfunction OT - peripheral T-cell lymphoma (PTCL) COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-2233/coif). The authors have no conflicts of interest to declare. EDAT- 2022/06/21 06:00 MHDA- 2022/06/21 06:01 PMCR- 2022/05/01 CRDT- 2022/06/20 04:07 PHST- 2022/03/29 00:00 [received] PHST- 2022/05/17 00:00 [accepted] PHST- 2022/06/20 04:07 [entrez] PHST- 2022/06/21 06:00 [pubmed] PHST- 2022/06/21 06:01 [medline] PHST- 2022/05/01 00:00 [pmc-release] AID - atm-10-10-570 [pii] AID - 10.21037/atm-22-2233 [doi] PST - ppublish SO - Ann Transl Med. 2022 May;10(10):570. doi: 10.21037/atm-22-2233.